Advertisement
Advertisement
PLSE
Pulse Biosciences, Inc Common Stock (DE)
42.41
USDSponsored
+4.17
+10.90%
Aug 07, 15:59 UTC -4
Closed
After-Market
42.23
-0.18
-0.42%
PLSE Earnings Reports
Positive Surprise Ratio
PLSE beat 12 of 25 last estimates.
48%
Next Report
Date of Next Report
Nov 03, 2026
Estimate for Q3 26 (Revenue/ EPS)
$748.00K
/-$0.36
Implied change from Q2 26 (Revenue/ EPS)
+73.95%
/--
Implied change from Q3 25 (Revenue/ EPS)
+769.76%
/+28.57%
Pulse Biosciences, Inc Common Stock (DE) earnings per share and revenue
On Aug 06, 2026, PLSE reported earnings of -0.36 USD per share (EPS) for Q2 26, beating the estimate of -0.36 USD, resulting in a 1.96% surprise. Revenue reached 430.00 thousand, compared to an expected 544.00 thousand, with a -20.96% difference. The market reacted with a +10.90% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.36 USD, with revenue projected to reach 748.00 thousand USD, implying an increase of 0.00% EPS, and increase of 73.95% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Teleflex Incorporated
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.29
Actual
$1.76
Surprise
+36.04%
GLOBUS MEDICAL INC
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.12
Actual
$1.34
Surprise
+19.50%
Tandem Diabetes Care, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.32
Actual
-$0.31
Surprise
+4.94%
Artivion, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.01
Actual
$0.13
Surprise
+1,174.51%
Delcath Systems Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.09
Actual
$0.07
Surprise
+176.25%
Treace Medical Concepts, Inc. Common Stock
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.30
Actual
-$0.24
Surprise
+21.05%
Inogen Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.15
Actual
-$0.14
Surprise
+10.88%
CVRx, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.53
Actual
-$0.53
Surprise
+0.90%
Rapid Micro Biosystems, Inc. Class A Common Stock
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.24
Actual
-$0.27
Surprise
-8.78%
Hyperfine, Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.09
Actual
-$0.09
Surprise
+1.96%
FAQ
What were Pulse Biosciences, Inc Common Stock (DE)'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Pulse Biosciences, Inc Common Stock (DE) reported EPS of -$0.36, beating estimates by 1.96%, and revenue of $430.00K, -20.96% below expectations.
How did the market react to Pulse Biosciences, Inc Common Stock (DE)'s Q2 2026 earnings?
The stock price moved up 10.9%, changed from $38.24 before the earnings release to $42.41 the day after.
When is Pulse Biosciences, Inc Common Stock (DE) expected to report next?
The next earning report is scheduled for Nov 03, 2026.
What are the forecasts for Pulse Biosciences, Inc Common Stock (DE)'s next earnings report?
Based on 3
analysts, Pulse Biosciences, Inc Common Stock (DE) is expected to report EPS of -$0.36 and revenue of $748.00K for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement